IRIS
CROCETTA, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 908
EU - Europa 579
AS - Asia 194
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
AF - Africa 1
Totale 1.688
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 903
IT - Italia 133
IE - Irlanda 119
SE - Svezia 114
CN - Cina 108
GB - Regno Unito 55
UA - Ucraina 53
TR - Turchia 40
FR - Francia 28
DE - Germania 25
SG - Singapore 21
RU - Federazione Russa 20
VN - Vietnam 13
FI - Finlandia 11
IN - India 7
CZ - Repubblica Ceca 5
CH - Svizzera 4
EU - Europa 4
PL - Polonia 3
BD - Bangladesh 2
BE - Belgio 2
BG - Bulgaria 2
MX - Messico 2
RS - Serbia 2
TH - Thailandia 2
BR - Brasile 1
CA - Canada 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NL - Olanda 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
Totale 1.688
Salva come PNG Salva come JPEG
Città #
Chandler 269
Dublin 118
Jacksonville 108
Ashburn 93
Chieti 62
Princeton 58
Southend 42
Dearborn 39
Ann Arbor 28
Nanjing 26
Wilmington 26
Beijing 25
Izmir 23
Washington 18
Singapore 14
Dong Ket 13
Altamura 12
Cambridge 12
Nanchang 9
Jiaxing 8
Kunming 8
Varallo 8
Vittuone 7
Norwalk 6
Rome 6
Woodbridge 6
Boardman 5
Monfalcone 5
Shenyang 5
Geneva 4
Tianjin 4
Changsha 3
Civitanova Marche 3
Edinburgh 3
Falls Church 3
Hefei 3
Los Angeles 3
Shanghai 3
Ankara 2
Bangkok 2
Belgrade 2
Brno 2
Brussels 2
Chicago 2
Ciudad de Villa de Alvarez 2
Delhi 2
Grevenbroich 2
Hebei 2
Lanzhou 2
Las Vegas 2
Molise 2
Napoli 2
New Delhi 2
Ningbo 2
Olomouc 2
Sofia 2
Warsaw 2
Amsterdam 1
Asunción 1
Augusta 1
Chaoyang 1
Dallas 1
Florence 1
Frankfurt am Main 1
Guangzhou 1
Hangzhou 1
Hanover 1
Helsinki 1
Houston 1
Jinan 1
Kuala Lumpur 1
Limana 1
London 1
Luxembourg 1
Manchester 1
Messina 1
Montreal 1
Oderzo 1
Orange 1
Orsogna 1
Panama City 1
Paris 1
Rzeszów 1
Saint Louis 1
San Juan 1
San Mateo 1
St Louis 1
São Paulo 1
Teramo 1
Trento 1
Udine 1
Villamagna 1
Totale 1.161
Salva come PNG Salva come JPEG
Nome #
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 114
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 96
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 91
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 76
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 76
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 75
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 74
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 73
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 71
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 68
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 66
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 63
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 62
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 57
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 56
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 56
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 55
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 53
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 52
Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year infection in the lungs of a cystic fibrosis patient 52
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 51
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 45
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 44
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis biofilm-related lung infections caused by Pseudomonas aeruginosa. 44
The importance of postmortem microbiological examination for the ex post diagnosis of infection: fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus. 41
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 40
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 40
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis lung infection caused by Pseudomonas aeruginosa 38
In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by Pseudomonas aeruginosa from Patients with Cystic Fibrosis 35
Potential Novel Therapeutic Strategies in Cystic Fibrosis: Antimicrobial and Anti-Biofilm Activity of Natural and Designed Alpha-Helical Peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 34
Toward optimization of a BMAP-derived antimicrobial peptide for the treatment of pulmonary infections caused by Pseudomonas aeruginosa in cystic fibrosis patients. 31
A longitudinal population genomic study of Stenotrophomonas maltophilia in cystic fibrosis patients: expanding our knowledge about an emerging opportunistic pathogen. 17
Totale 1.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020251 57 12 4 2 30 25 32 20 6 20 41 2
2020/2021196 22 10 53 8 15 33 2 4 7 15 7 20
2021/2022207 1 11 3 49 4 2 2 14 12 1 36 72
2022/2023586 47 85 54 77 40 106 24 43 75 5 23 7
2023/2024261 11 12 32 18 22 81 38 19 1 4 3 20
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 1.846